US5208230A
(en)
*
|
1990-12-21 |
1993-05-04 |
Merrell Dow Pharmaceuticals |
Amino and nitro containing tricyclic compounds useful as inhibitors of ACE
|
ATE158303T1
(de)
*
|
1990-12-21 |
1997-10-15 |
Merrell Pharma Inc |
Neue trizyklische amino- und nitro verbindungen mit ace-hemmenden eigenschaften
|
US5457196A
(en)
*
|
1991-09-27 |
1995-10-10 |
Merrell Dow Pharmaceuticals Inc. |
2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE
|
CA2078758C
(en)
*
|
1991-09-27 |
2003-12-09 |
Alan M. Warshawsky |
2-substituted indane-2-mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
|
US5455242A
(en)
*
|
1991-09-27 |
1995-10-03 |
Merrell Dow Pharmaceuticals Inc. |
Carboxyalkyl tricyclic derivatives useful as inhibitors of enkephalinase and ace
|
CA2078759C
(en)
*
|
1991-09-27 |
2003-09-16 |
Alan M. Warshawsky |
Novel carboxyalkyl derivatives useful as inhibitors of enkephalinase and ace
|
AU657793B2
(en)
*
|
1991-09-27 |
1995-03-23 |
Merrell Pharmaceuticals Inc. |
Novel 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE
|
JP3460838B2
(ja)
*
|
1992-02-14 |
2003-10-27 |
メレルファーマスーティカルズインコーポレイテッド |
エンケファリナーゼ及びaceの阻害剤として有用な,アミノアセチルメルカプトアセチルアミド誘導体類
|
US5552397A
(en)
*
|
1992-05-18 |
1996-09-03 |
E. R. Squibb & Sons, Inc. |
Substituted azepinone dual inhibitors of angiotensin converting enzyme and neutral exdopeptidase
|
DE69325904T2
(de)
*
|
1992-05-15 |
1999-12-09 |
Merrell Pharma Inc |
MERCAPTOACETYLAMIDE VON PYRIDAZO[1,2-a][1,2]-DIAZEPIN -DERIVATEN ALS EUKEPHALINASE UND ACE-INHIBITOREN
|
RU2124503C1
(ru)
*
|
1992-05-18 |
1999-01-10 |
И.Р.Сквибб энд Санз, Инк. |
Гетероциклические азотсодержащие производные карбоновой кислоты, способ их получения и фармацевтическая композиция
|
US5238932A
(en)
*
|
1992-05-20 |
1993-08-24 |
Merrell Dow Pharmaceuticals Inc. |
Mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase
|
US5298492A
(en)
*
|
1992-08-04 |
1994-03-29 |
Schering Corporation |
Diamino acid derivatives as antihypertensives
|
DE69326474T2
(de)
*
|
1992-08-24 |
2000-02-17 |
Merrell Pharma Inc |
Neue 2-substituierte tricyclische derivate von indan-2-mercaptoacetylamid verwendbar als enkephalinase inhibitoren
|
US5208236A
(en)
*
|
1992-09-23 |
1993-05-04 |
Schering Corporation |
N-(acylaminomethyl)glutaryl amino acids and use
|
US5504080A
(en)
*
|
1992-10-28 |
1996-04-02 |
Bristol-Myers Squibb Co. |
Benzo-fused lactams
|
PT669936E
(pt)
*
|
1992-10-30 |
2001-04-30 |
Merrell Pharma Inc |
Derivados de lactama biciclica de mercaptoacetilamida uteis como inibidores de encefalinase e de ace
|
US5654294A
(en)
*
|
1993-05-13 |
1997-08-05 |
Bristol-Myers Squibb |
Spiro lactam dual action inhibitors
|
GB9310075D0
(en)
*
|
1993-05-17 |
1993-06-30 |
Fujisawa Pharmaceutical Co |
New mercapto-amide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
|
CN1110865A
(zh)
*
|
1993-06-11 |
1995-10-25 |
卫材株式会社 |
氨基酸衍生物
|
AU680512B2
(en)
*
|
1993-06-11 |
1997-07-31 |
Eisai Co. Ltd. |
Amino acid derivative
|
US5508272A
(en)
*
|
1993-06-15 |
1996-04-16 |
Bristol-Myers Squibb Company |
Compounds containing a fused bicycle ring and processes therefor
|
US5644055A
(en)
*
|
1993-06-30 |
1997-07-01 |
Ciba-Geigy Corporation |
Antihypertensive tricyclic azepine derivatives useful as inhibitors of enkephalinase and ACE
|
ES2076096B1
(es)
*
|
1993-07-14 |
1996-03-16 |
Squibb & Sons Inc |
Compuestos inhibidores de la enzima convertidora de angiotensinas y dela endopeptidasa neutra, y metodos para prepararlos.
|
US5362727A
(en)
*
|
1993-07-26 |
1994-11-08 |
Bristol-Myers Squibb |
Substituted azepino[2,1-a]isoquinoline compounds
|
US5525723A
(en)
*
|
1993-11-18 |
1996-06-11 |
Bristol-Myers Squibb Co. |
Compounds containing a fused multiple ring lactam
|
HUT74385A
(en)
*
|
1994-02-14 |
1996-12-30 |
Merrell Pharma Inc |
Novel mercaptoacetylamido 1,3,4,5-tetrahydro-benzo[c]azepin-3-one disulfide derivatives useful as inhibitors of enkephalinase and ace
|
WO1995021840A1
(en)
*
|
1994-02-14 |
1995-08-17 |
Merrell Pharmaceuticals Inc. |
Novel indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase
|
CN1142831A
(zh)
*
|
1994-02-14 |
1997-02-12 |
默里尔药物公司 |
用作脑啡肽酶和ace抑制剂的新的2-取代的1,2-二氢化茚-2-巯基乙酰胺二硫化物衍生物
|
ATE177098T1
(de)
*
|
1994-02-14 |
1999-03-15 |
Merrell Pharma Inc |
Mercaptoacetylamid disulfidderivate als enkephalinase und ace inhibitoren
|
US5530013A
(en)
*
|
1994-02-14 |
1996-06-25 |
American Home Products Corporation |
Venlafaxine in the inducement of cognition enhancement
|
US5484783A
(en)
*
|
1994-03-24 |
1996-01-16 |
Merrell Dow Pharmaceuticals Inc. |
Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide and benzazapine derivatives
|
AU698320B2
(en)
*
|
1994-03-24 |
1998-10-29 |
Merrell Pharmaceuticals Inc. |
Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic aminoacetylmercapto derivatives
|
HUP9774624A2
(en)
*
|
1994-03-24 |
1997-01-28 |
Merrell Pharma Inc |
Hypocholesterolemic, antiatheroclerotic and hypotriglyceridemic condensed benzazepine mercaptoacetylamide disulfide derivatives
|
US5616775A
(en)
*
|
1994-05-05 |
1997-04-01 |
Bristol-Myers Squibb Co. |
Process for preparing homocystein analogs useful as intermediates for compounds containing a fused bicyclic ring
|
US5641880A
(en)
*
|
1994-12-21 |
1997-06-24 |
Hoechst Marion Roussel, Inc. |
Processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof
|
AU689362B2
(en)
*
|
1994-12-21 |
1998-03-26 |
Aventis Pharmaceuticals Inc. |
Novel processes for preparing intermediates of inhibitors ofenkephalinase and angiotensin converting enzyme and intermediates thereof
|
US5587375A
(en)
*
|
1995-02-17 |
1996-12-24 |
Bristol-Myers Squibb Company |
Azepinone compounds useful in the inhibition of ACE and NEP
|
US5877313A
(en)
|
1995-05-17 |
1999-03-02 |
Bristol-Myers Squibb |
Benzo-fused azepinone and piperidinone compounds useful in the inhibition of ACE and NEP
|
US5635504A
(en)
*
|
1995-06-07 |
1997-06-03 |
Bristol-Myers Squibb Co. |
Diazepine containing dual action inhibitors
|
US5650408A
(en)
*
|
1995-06-07 |
1997-07-22 |
Karanewsky; Donald S. |
Thiazolo benzazepine containing dual action inhibitors
|
JP4588877B2
(ja)
|
1998-06-17 |
2010-12-01 |
ブリストル−マイヤーズ スクイブ カンパニー |
Adp−受容体抗血小板物質と抗高血圧薬の組合せ投与による脳梗塞の予防
|
SE9903028D0
(sv)
|
1999-08-27 |
1999-08-27 |
Astra Ab |
New use
|
DE60022525T2
(de)
|
1999-08-30 |
2006-06-14 |
Sanofi Aventis Deutschland |
Ramipril zur vorbeugung von kardiovaskulären vorfällen
|
JP4392167B2
(ja)
*
|
2001-04-12 |
2009-12-24 |
サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング |
メルカプトアセチルアミド誘導体、その製造方法およびその使用
|
GB0119305D0
(en)
|
2001-04-12 |
2001-10-03 |
Aventis Pharma Gmbh |
Mercaptoacetylamide derivatives,a process for their preparation and their use
|
AU2002348276A1
(en)
|
2001-11-16 |
2003-06-10 |
Bristol-Myers Squibb Company |
Dual inhibitors of adipocyte fatty acid binding protein and keratinocyte fatty acid binding protein
|
DE10212198A1
(de)
*
|
2002-03-19 |
2003-10-02 |
Aventis Pharma Gmbh |
Ethan-1-diaminium-bis(2R)-2-brom-3-phenylpropanoat), Verfahren zu dessen Herstellung und dessen Verwendung
|
US7009047B2
(en)
|
2002-03-19 |
2006-03-07 |
Sanofi-Aventis Deutschland Gmbh |
Ethane-1,2-diaminium bis[(2R)-2-bromo-3-phenylpropanoate], processes for its preparation and its use
|
DE10229180A1
(de)
*
|
2002-06-28 |
2004-01-29 |
Aventis Pharma Deutschland Gmbh |
Verwendung von Vasopeptidase-Inhibitoren bei der Behandlung von metabolischen Erkrankungen, Nephropathie und mit AGE assoziierten Erkrankungen
|
JP2006522746A
(ja)
|
2003-04-11 |
2006-10-05 |
ノボ ノルディスク アクティーゼルスカブ |
置換されたアミドの薬学的使用
|
US7459474B2
(en)
|
2003-06-11 |
2008-12-02 |
Bristol-Myers Squibb Company |
Modulators of the glucocorticoid receptor and method
|
US7371759B2
(en)
|
2003-09-25 |
2008-05-13 |
Bristol-Myers Squibb Company |
HMG-CoA reductase inhibitors and method
|
US7420059B2
(en)
|
2003-11-20 |
2008-09-02 |
Bristol-Myers Squibb Company |
HMG-CoA reductase inhibitors and method
|
US7273881B2
(en)
|
2004-01-16 |
2007-09-25 |
Bristol-Myers Squibb Company |
Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
|
EA011097B1
(ru)
|
2004-05-07 |
2008-12-30 |
Янссен Фармацевтика Н.В. |
Производные пирролидин-2-она и пиперидин-2-она, используемые в качестве ингибиторов 11-бета-гидроксистероид-дегидрогеназы
|
FR2872164B1
(fr)
*
|
2004-06-29 |
2006-11-17 |
Aventis Pharma Sa |
Derives de quinoleines-4-substituees, leur procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent
|
DE602005017159D1
(de)
|
2004-08-30 |
2009-11-26 |
Janssen Pharmaceutica Nv |
Oxysteroid-dehydrogenase-inhibitoren
|
US7888381B2
(en)
|
2005-06-14 |
2011-02-15 |
Bristol-Myers Squibb Company |
Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity, and use thereof
|
US7592461B2
(en)
|
2005-12-21 |
2009-09-22 |
Bristol-Myers Squibb Company |
Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
|
US7795291B2
(en)
|
2006-07-07 |
2010-09-14 |
Bristol-Myers Squibb Company |
Substituted acid derivatives useful as anti-atherosclerotic, anti-dyslipidemic, anti-diabetic and anti-obesity agents and method
|
EP2089355A2
(de)
|
2006-11-01 |
2009-08-19 |
Brystol-Myers Squibb Company |
Modulatoren der glucocorticoidrezeptor-, ap-1- und/oder nf-kappa-b-aktivität und deren verwendung
|
WO2008057857A1
(en)
|
2006-11-01 |
2008-05-15 |
Bristol-Myers Squibb Company |
MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-ϰB ACTIVITY AND USE THEREOF
|
US7994190B2
(en)
|
2006-11-01 |
2011-08-09 |
Bristol-Myers Squibb Company |
Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
|
WO2008151257A2
(en)
|
2007-06-04 |
2008-12-11 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
US8106046B2
(en)
|
2008-06-24 |
2012-01-31 |
Bristol-Myers Squibb Company |
Cyclopentathiophene modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
|
AU2009270833B2
(en)
|
2008-07-16 |
2015-02-19 |
Bausch Health Ireland Limited |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
|
EA020496B1
(ru)
|
2008-11-21 |
2014-11-28 |
ХАЙ ПОЙНТ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи |
Производное адамантилбензамида, фармацевтическая композиция, включающая его, и его применение
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
EP2968439A2
(de)
|
2013-03-15 |
2016-01-20 |
Synergy Pharmaceuticals Inc. |
Zusammensetzungen zur behandlung von magen-darm-störungen
|
CA2905438A1
(en)
|
2013-03-15 |
2014-09-25 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase and their uses
|
US10011637B2
(en)
|
2013-06-05 |
2018-07-03 |
Synergy Pharmaceuticals, Inc. |
Ultra-pure agonists of guanylate cyclase C, method of making and using same
|
US9593113B2
(en)
|
2013-08-22 |
2017-03-14 |
Bristol-Myers Squibb Company |
Imide and acylurea derivatives as modulators of the glucocorticoid receptor
|